tm
Seeing Is Believing
tm
Seeing Is Believing
MLYS is currently covered by 7 analysts with an average price target of $47.86. This is a potential upside of $15.93 (57.12%) from yesterday's end of day stock price of $30.46.
Mineralys Therapeutics, Common Stock's activity chart (see below) currently has 39 price targets and 42 ratings on display. The stock rating distribution of MLYS is 23.08% HOLD and 76.92% BUY.
Analysts average stock forecasts to be materialized ratio is 75.68% with an average time for these price targets to be met of 471.13 days.
Highest price target for MLYS is $56, Lowest price target is $26, average price target is $47.86.
Most recent stock forecast was given by from BAML on 13-Mar-2026. First documented stock forecast 07-Mar-2023.
Currently out of the existing stock ratings of MLYS, 3 are a HOLD (23.08%), 10 are a BUY (76.92%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Mar-2023
$51
$24.32 (91.15%)
$38
3 months 25 days ago
(13-Mar-2026)
2/3 (66.67%)
$24.81 (94.73%)
553
Buy Since 07-Mar-2023
$52
$25.32 (94.90%)
$45
6 months 19 days ago
(19-Dec-2025)
5/6 (83.33%)
$15.17 (41.19%)
433
Buy Since 10-Jul-2024
$56
$29.32 (109.90%)
$52
7 months 26 days ago
(12-Nov-2025)
11/13 (84.62%)
$8.67 (18.32%)
213
Buy Since 07-Mar-2023
$55
$28.32 (106.15%)
$50
7 months 27 days ago
(11-Nov-2025)
1/3 (33.33%)
$7.89 (16.75%)
910
Buy Since 07-Mar-2023
$52
$25.32 (94.90%)
$24
9 months 29 days ago
(09-Sep-2025)
7/8 (87.5%)
$13.5 (35.06%)
652
What is MLYS (Mineralys Therapeutics, Common Stock) average time for price targets to be met?
Which analyst has the current highest performing score on MLYS (Mineralys Therapeutics, Common Stock) with a proven track record?
Which analyst has the most public recommendations on MLYS (Mineralys Therapeutics, Common Stock)?
Which analyst is the currently most bullish on MLYS (Mineralys Therapeutics, Common Stock)?
Which analyst is the currently most reserved on MLYS (Mineralys Therapeutics, Common Stock)?
